Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2000
12/12/2000US6159491 Prolonged release bioadhesive vaginal gel dosage form
12/12/2000US6159488 Polymer carrier; prevention restenosis after angioplasty
12/12/2000US6159485 Cosmetics; skin disorders
12/12/2000US6159478 Genetic engineering
12/12/2000US6159477 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus
12/12/2000US6159476 Herbal supplement for increased muscle strength and endurance for athletes
12/12/2000US6159468 Activated protein C formulations
12/12/2000US6159459 Oral lubricating composition
12/12/2000US6159458 Sustained release ophthalmic compositions containing water soluble medicaments
12/12/2000US6159455 Applying to skin, hair
12/12/2000US6159454 Use of cholesteric liquid-crystalline polymers as UV screens in cosmetic and pharmaceutical preparations
12/12/2000US6159450 Use of Ginkgo biloba flavonoidic extract substantially devoid of terpenes for oral hygiene and composition containing such extract
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000US6159347 Methods for separating a tocol from a tocol-containing mixture
12/12/2000CA2186867C Methods of using iron chelating compounds to reduce free radical damage in mammals
12/12/2000CA2168247C Nitric oxide donor composition and method for treatment of anal disorders
12/12/2000CA2167397C Indoles
12/12/2000CA2160881C 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents
12/12/2000CA2131186C Isosteric antiherpes peptide derivatives
12/12/2000CA2063417C Antiviral composition
12/12/2000CA2058560C Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
12/12/2000CA2046997C Liposomal products
12/12/2000CA2036413C Hiv protease inhibitors
12/12/2000CA2023560C 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
12/11/2000CA2274414A1 Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
12/10/2000CA2311039A1 Rapidly absorbed liquid compositions
12/07/2000WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor
12/07/2000WO2000073791A1 Remedies for kidney diseases and method for screening the same
12/07/2000WO2000073788A1 Use of gabapentin in assays to identify gabab receptor modulators
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073501A2 Nucleic acid molecules with specific identification of native prpsc, their production and the use thereof
12/07/2000WO2000073469A2 Protein kinases
12/07/2000WO2000073463A1 Groel muteins with improved stability
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073448A1 Adipocyte complement related protein homolog zacrp7
12/07/2000WO2000073374A1 Silicone gel containing salicylic acid
12/07/2000WO2000073336A1 Fimbrial proteins
12/07/2000WO2000073330A2 Method and compositions relating to insulin resistance disorders
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073313A1 New tricyclic amidine derivatives as inhibitors of nitric oxide synthase
12/07/2000WO2000073309A1 Pyrozolo [3,4-d][1,2,3] triazines with an anticonvulsive action and methods for producing the same
12/07/2000WO2000073307A2 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000WO2000073306A1 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
12/07/2000WO2000073304A1 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
12/07/2000WO2000073303A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/07/2000WO2000073301A1 Bicyclic oxazolidinones as antibacterial agent
12/07/2000WO2000073300A1 Amino heterocycles useful as pharmaceutical agents
12/07/2000WO2000073299A1 Sulfonamide compounds with pharmaceutical activity
12/07/2000WO2000073298A1 Mutual prodrugs of amlodipine and atorvastatin
12/07/2000WO2000073296A2 3-heteroarylalkyl substituted gaba analogs
12/07/2000WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073293A1 Semi-synthesis of paclitaxel using dialkyldichlorosilanes
12/07/2000WO2000073292A1 Biaryl compounds
12/07/2000WO2000073283A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073279A1 4-phenyl-pyrimidine derivatives
12/07/2000WO2000073278A2 5-phenyl-pyrimidine derivatives
12/07/2000WO2000073276A2 Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000WO2000073275A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000WO2000073274A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
12/07/2000WO2000073271A1 Mutual salt of amlodipine and atorvastatin
12/07/2000WO2000073270A1 Remedies for periodontal diseases
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000073265A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors
12/07/2000WO2000073264A1 Cell proliferation inhibitors
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000073260A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000WO2000073259A1 Fused polycyclic amino acids as pharmaceutical agents
12/07/2000WO2000073253A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-α MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS
12/07/2000WO2000072920A1 Substituted biaryl ether compounds
12/07/2000WO2000072885A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000WO2000072884A1 A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
12/07/2000WO2000072871A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000WO2000072865A2 Antifungal combination use
12/07/2000WO2000072862A1 Cranberry seed oil extract and compositions containing components thereof
12/07/2000WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
12/07/2000WO2000072853A1 Chemical composition, fabrication procedure and treatment methodology based on it, as cancer medication
12/07/2000WO2000072851A1 Method of sterilizing
12/07/2000WO2000072850A1 Foot care compositions containing quaternary ammonium organosilanes
12/07/2000WO2000072849A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
12/07/2000WO2000072848A1 Composition comprising (±)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1h,5h)-pyrimidinedione dissolved in 2,5-di-o-methyl-1,4:3,6-dianhydro-d-glucitol
12/07/2000WO2000072847A1 Ziprasidone suspension
12/07/2000WO2000072846A1 Antibacterial compounds
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072844A1 Neuronal death inhibitors
12/07/2000WO2000072843A1 Therapeutic use of melatonin
12/07/2000WO2000072842A1 Nutritional supplements
12/07/2000WO2000072841A1 Compounds and methods for the treatment of post traumatic stress disorder
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072839A1 Antiseptic spermicidal composition and means for its application
12/07/2000WO2000072838A1 New use of compounds as antibacterial agents
12/07/2000WO2000072837A2 Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
12/07/2000WO2000072836A2 Methods of promoting or enhancing interleukin-12 production through administration of thalidomide
12/07/2000WO2000072835A2 Topical application of muscarinic and opioid agents for treatment of tinnitus
12/07/2000WO2000072834A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
12/07/2000WO2000072833A2 Pharmaceutical preparations for inhibiting sphingomyelinase
12/07/2000WO2000072832A2 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts
12/07/2000WO2000072831A1 Nutritional formulations
12/07/2000WO2000072829A1 Novel formulations comprising lipid-regulating agents
1 ... 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 ... 7860